From March 24, 2022 to March 31, 2022, the company has repurchased 211,333 shares, representing 0.59% for KRW 3,982.64 million. With this, the company has completed the repurchase of 211,333 shares, representing 0.59% for KRW 3,982.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,910 KRW | +4.07% |
|
+3.75% | -22.97% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-22.97% | 163M | |
-10.83% | 11.24B | |
-15.14% | 7.29B | |
+29.34% | 5.57B | |
+0.04% | 5.31B | |
-19.93% | 3.68B | |
+7.75% | 2.58B | |
-66.10% | 2.33B | |
-11.20% | 2.23B | |
+24.09% | 2.21B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.